Case-Based Roundtable Meetings Spotlight: September 2022

Roundtable Discussion: Panelists Debate Therapy Options for R/R Multiple Myeloma With Renal Impairment

September 29, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Saad Z. Usmani, MD, MBC, discussed the case of a patient who progressed on first- and second-line therapy for multiple myeloma and did not receive a stem cell transplant.

Roundtable Discussion: Hamilton Compares Therapy Options and Sequencing for Recurrent TNBC

September 25, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Erika P. Hamilton, MD, discussed the choice of first- and second-line therapy for a patient with triple-negative breast cancer following adjuvant chemotherapy.

Lee Reviews Trials Supporting IO/TKI Combinations in Frontline RCC

September 23, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Chung-Han Lee, MD, PhD, discussed the latest data supporting the use of lenvatinib/pembrolizumab as frontline therapy for patients with advanced clear cell renal cell carcinoma.

Roundtable Discussion: Iams Considers Platinum Rechallenge or Other Therapy for Relapsed ES-SCLC

September 22, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Wade T. Iams, MD, discussed the case of a patient who progressed following a partial response to platinum-based chemotherapy for extensive-stage small cell lung cancer.